The U.S. Food and Drug Administration's FDA has approved emergency use of the pharmaceutical company Johnson & Johnson's COVID-19 vaccine, the Associated Press reported.

The FDA accepted one day after the Vaccine Advisory Committee voted to approve emergency use of Johnson & Johnson's COVID-19 vaccine for immunization to adult Americans over the age of 18.

As a result, the United States has secured a third COVID-19 vaccine available to Americans, following the vaccines of Pfizer-Bioentech and Modena.